Does RAMIPRIL Cause Malignant neoplasm progression? 63 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Malignant neoplasm progression have been filed in association with RAMIPRIL (Ramipril). This represents 0.2% of all adverse event reports for RAMIPRIL.
63
Reports of Malignant neoplasm progression with RAMIPRIL
0.2%
of all RAMIPRIL reports
6
Deaths
36
Hospitalizations
How Dangerous Is Malignant neoplasm progression From RAMIPRIL?
Of the 63 reports, 6 (9.5%) resulted in death, 36 (57.1%) required hospitalization, and 2 (3.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMIPRIL. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does RAMIPRIL Cause?
Acute kidney injury (3,286)
Dyspnoea (2,537)
Dizziness (2,490)
Hypotension (2,417)
Fatigue (2,415)
Drug ineffective (2,412)
Nausea (2,219)
Vomiting (2,055)
Off label use (2,053)
Hypertension (2,046)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which RAMIPRIL Alternatives Have Lower Malignant neoplasm progression Risk?
RAMIPRIL vs RAMUCIRUMAB
RAMIPRIL vs RANEXA
RAMIPRIL vs RANIBIZUMAB
RAMIPRIL vs RANIMUSTINE
RAMIPRIL vs RANITIDINE